The effect of bowel resection on survival in advanced epithelial ovarian cancer

被引:63
|
作者
Jaeger, W
Ackermann, S
Kessler, H
Katalinic, A
Lang, N
机构
[1] Univ Erlangen Nurnberg, Frauenklin, Dept Obstet & Gynecol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Surg, D-91054 Erlangen, Germany
[3] Univ Luebeck, Inst Canc Epidemiol, Lubeck, Germany
关键词
ovarian cancer; surgical treatment; bowel metastases; bowel resection;
D O I
10.1006/gyno.2001.6375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. FIGO stage III ovarian cancer is further categorized according to the size of tumor, but not according to the organs affected. In this study we evaluated the outcome of patients with and without macroscopic bowel involvement in stage III ovarian cancer. Methods. This retrospective study analyzed the outcome of 194 ovarian cancer patients with FIGO III with and without bowel involvement who were operated on in our institution between 1985 and 1994. Results. The study demonstrated that maximum tumor reduction without remaining macroscopic cancer offered the best overall survival times in FIGO III ovarian cancer patients. However, whenever the bowel was involved, even maximum bowel resections did not prolong survival compared to patients with remaining tumor after surgery. Conclusions. This retrospective study demonstrated that bowel involvement in ovarian cancer had a bad prognosis and that survival in these patients could not substantially be prolonged when the affected parts of bowel were resected. To further substantiate these findings, future studies on advanced ovarian cancer should differentiate between patients with and without bowel involvement. (C) 2001 Academic Press.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 50 条
  • [21] Malignant bowel obstruction in advanced ovarian cancer
    Dean, Emma
    Khoja, Leila
    Clamp, Andrew
    Jayson, Gordon C.
    Goonetilleke, Dilly
    Conway, Alicia M.
    Hasan, Jurjees
    FUTURE ONCOLOGY, 2017, 13 (06) : 513 - 521
  • [22] The insolvable problem; survival effect of lymphadenectomy in advanced stage ovarian cancer
    Bakir, Mehmet Sait
    Birge, Ozer
    Karadag, Ceyda
    Dogan, Selen
    Tuncer, Hasan Aykut
    Simsek, Tayup
    GINEKOLOGIA POLSKA, 2021, 92 (12) : 829 - 836
  • [23] Association of lymphadenectomy and survival in epithelial ovarian cancer
    Ercelep, Ozlem
    Ozcelik, Melike
    Gumus, Mahmut
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 151 - 159
  • [24] The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer
    Bachmann, Robert
    Rothmund, Ralf
    Kraemer, Bernhard
    Brucker, Sara Y.
    Koenigsrainer, Alfred
    Koenigsrainer, Ingmar
    Beckert, Stefan
    Staebler, Anette
    Phuc NguyenHuu
    Grischke, Eva
    Wallwiener, Diethelm
    Bachmann, Cornelia
    JOURNAL OF INVESTIGATIVE SURGERY, 2015, 28 (03) : 160 - 166
  • [25] Prognostic Value of En-Block Radical Bowel Resection in Advanced Ovarian Cancer Surgery With HIPEC
    Panoskaltsis, T.
    Papadimitriou, C.
    Pallas, N.
    Karamveri, C.
    Kyziridis, D.
    Hristakis, C.
    Kiriakopoulos, V.
    Kalakonas, A.
    Vaikos, D.
    Tzavara, C.
    Tentes, A. A.
    CANCER CONTROL, 2023, 30
  • [26] The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients
    Ye, Shuang
    Wang, Yiyong
    Chen, Lei
    Wu, Xiaohua
    Yang, Huijuan
    Xiang, Libing
    BMC SURGERY, 2022, 22 (01)
  • [27] The role of bowel surgery with cytoreduction for epithelial ovarian cancer
    Cai, H. -B.
    Zhou, Y. -F.
    Chen, H. -Z.
    Hou, H. -Y.
    CLINICAL ONCOLOGY, 2007, 19 (10) : 757 - 762
  • [28] The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients
    Shuang Ye
    Yiyong Wang
    Lei Chen
    Xiaohua Wu
    Huijuan Yang
    Libing Xiang
    BMC Surgery, 22
  • [29] The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer
    Kroep, Judith R.
    Nortier, Johan W. R.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) : 3775 - 3783
  • [30] Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer
    Nasioudis, Dimitrios
    Byrne, Maureen
    Ko, Emily M.
    Haggerty, Ashley F.
    Cory, Lori
    Giuntoli, Robert L., II
    Kim, Sarah H.
    Latif, Nawar A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (12) : 1579 - 1583